GM herpes virus fights advanced cancers
Potential of immunotherapy in head and neck cancer | VJOncology
Dr. Harrington on the KEYNOTE-048 Trial in Recurrent/Metastatic Head and Neck Cancer
Professor Kevin Harrington | The Royal Marsden
World's first centre for recurrent head and neck cancer launched - Professor Christopher Nutting Oncology
Kevin HARRINGTON | Institute of Cancer Research, London | Division of Radiotherapy and Imaging
ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London
Scientific Advisory Board – PsiVac
Royal Marsden staff among world's top influential researchers | The Royal Marsden Cancer Charity
The ICR on Twitter: "🧬 The ICR's Professor Kevin Harrington and his team are using viral #Immunotherapy to harness the body's immune system to kill cancer. See their research with T-VEC, a
Professor Kevin Harrington - The Institute of Cancer Research, London
Professor Kevin Harrington to star in BBC2's Trust me, I'm a Doctor - The Institute of Cancer Research, London
Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations? - touchONCOLOGY
Royal Marsden researchers named among world's most influential scientists | The Royal Marsden
Professor Kevin Harrington - YouTube
6th OF NOVEMBER 12:00-13:00
Mary Tanay RN on Twitter: "What does the future hold for head & neck cancers. An evening of the latest clinical research innovations, cancer care & treatment. Co-chairs: Prof Harrington & patient
New treatment destroys head and neck cancer tumours in trial | Cancer | The Guardian
Private Care – Summer 2016 by The Royal Marsden - Issuu
Professor Kevin Harrington - The Institute of Cancer Research, London
Potential of immunotherapy in head and neck cancer | VJOncology
